Background The widespread mobilisation to improve maternal health over recent decades has led to increased prenatal ...

Objective Sarcopenia, defined by reductions in muscle mass and strength, increases the risk of adverse outcomes in patients with rheumatoid arthritis (RA)—driven in part by chronic inflammation—and is ...

Objective SLE is a heterogeneous systemic autoimmune disease with diverse clinical manifestations. We aimed to identify ...

The field of statistics is a fundamental cornerstone of clinical and public health research, playing a key role in improving scientific understanding and developing successful health policy. This ...

This is an introductory course on statistics and how it can help us answer the kind of questions that arise when we want to better understand the world. We will use real-world examples from the social ...

There’s no shortage of interesting facts about the world and the people who live in it. That, of course, includes some very quirky ones right here in the USA. Like what? We’re so glad you asked! Read ...

Katherine Haan, MBA, is a Senior Staff Writer for Forbes Advisor and a former financial advisor turned international bestselling author and business coach. For more than a decade, she’s helped small ...

Penny Gusner is a senior insurance writer and analyst at Forbes Advisor. For more than 20 years, she has been helping consumers learn how insurance laws, data, trends, and coverages affect them. Penny ...

Explore a selection of reports and publications from the experts at Cancer Research UK, and through various collaborations. Topics include: summaries of the state of cancer, projections, risk factors ...

Admissions Statistics for Medicine & Dentistry We have split our Admissions statistics by course and fee status as we rank Home and Overseas fee payers separately when shortlisting for interview, and ...

At London Business School, we believe business is about people, ideas and impact. Experience world‑class Executive Education, with open and custom programmes ranked #1 and #2 by the Financial Times.